Current Alzheimer Research
Title:Meet Our Editorial Board Member
Volume: 14 Issue: 6
Author(s): Othman Ghribi*
Affiliation:
- School of Medicine and Health Sciences Room University of North Dakota Grand Forks, ND,United States
Export Options
About this article
Cite this article as:
Ghribi Othman*, Meet Our Editorial Board Member, Current Alzheimer Research 2017; 14 (6) . https://dx.doi.org/10.2174/156720501406170509185239
DOI https://dx.doi.org/10.2174/156720501406170509185239 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
18
2
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Recent Evidence in Epigenomics and Proteomics Biomarkers for Early and Minimally Invasive Diagnosis of Alzheimer’s and Parkinson’s Diseases
Current Neuropharmacology Telmisartan Promotes Potential Glucose Homeostasis in Stroke-Resistant Spontaneously Hypertensive Rats via Peroxisome Proliferator-Activated Receptor γ Activation
Current Neurovascular Research An Update on Natural Occurrence and Biological Activity of Chromones
Current Medicinal Chemistry Inhibitory Mechanisms of Antibiotics Targeting Elongation Factor Tu
Current Protein & Peptide Science Alpha-Secretase As a Therapeutic Target
Current Alzheimer Research Molecular and Biochemical Features in Alzheimers Disease
Current Pharmaceutical Design Editorial (Thematic Issue: Role of Antioxidants Treatments on Oxidative Stress and Calcium Entry in Neurological Disease: Focus on TRP Channels)
Current Neuropharmacology Microenvironmental Determinants of Adult Neural Stem Cell Proliferation and Lineage Commitment in the Healthy and Injured Central Nervous System
Current Stem Cell Research & Therapy Synthetic Cannabinoid Receptor Agonists and Antagonists: Implication in CNS Disorders
Recent Patents on CNS Drug Discovery (Discontinued) Structural and Aggregation Properties of Alpha-Synuclein Linked to Phospholipase A2 Action
Protein & Peptide Letters The Many Faces of Tourette Syndrome
Current Drug Therapy Dexmedetomidine Use in General Anaesthesia
Current Drug Targets Differential Up-Regulation of Ammonia Detoxifying Enzymes in Cerebral Cortex, Cerebellum, Hippocampus, Striatum and Liver in Hyperammonemia
CNS & Neurological Disorders - Drug Targets Targeting Parkinson’s - Tyrosine Hydroxylase and Oxidative Stress as Points of Interventions
CNS & Neurological Disorders - Drug Targets Editorial [Hot Topic:Nicotinamide Adenine Dinucleotide Biology and Disease(Executive Editor: W. Todd Penberthy)]
Current Pharmaceutical Design Mechanisms of Action of DNA-Damaging Anticancer Drugs in Treatment of Carcinomas: Is Acute Apoptosis an “Off-Target” Effect?
Mini-Reviews in Medicinal Chemistry Distribution of Synthetic Cannabinoids JWH-210, RCS-4 and Δ 9-Tetrahydrocannabinol After Intravenous Administration to Pigs
Current Neuropharmacology Schizophrenia: Redox Regulation and Volume Neurotransmission
Current Neuropharmacology Editorial [Hot Topic: Compliance, Adherence and Concordance in Medicine Taking of Psychiatric Patients (Guest Editor: Carlos De las Cuevas)]
Current Clinical Pharmacology Pharmacological Support of Neurorehabilitation
Current Drug Therapy